Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples